Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: Enough Data to be Considered Effective?

Volume: 20, Issue: 5, Pages: 1186 - 1187
Published: May 1, 2022
Abstract
We read with great interest the article by Jirapinyo et al1Jirapinyo P. et al.Clin Gastroenterol Hepatol. 2022; 20: 511-524.e1Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar on “The effect of endoscopic bariatric and metabolic therapies on nonalcoholic fatty liver disease: a systematic review and meta-analysis.” After conducting a meta-analysis, the authors conclude that endoscopic bariatric and metabolic therapies (EBMTs)...
Paper Details
Title
Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: Enough Data to be Considered Effective?
Published Date
May 1, 2022
Volume
20
Issue
5
Pages
1186 - 1187
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.